Shorter Crohn’s Disease Duration is Associated with Better Clinical and Endoscopic Outcomes with Risankizumab in Phase 3 Studies
Gastro Hep Advances(2024)
关键词
biologics,Crohn’s disease,disease duration,interleukin 23,risankizumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要